FLT3 and acute myeloid leukemia: Elevated ULBP1 and FLT3 expression was also observed in bone marrow cells of AML-bearing mice treated with gilteritinib monotherapy or gilteritinib combined with CAR T cells (all p < 0.05 compared with controls) (Fig. 5D, E).